{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:26:47Z","timestamp":1776882407820,"version":"3.51.2"},"reference-count":0,"publisher":"Academy of Managed Care Pharmacy","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMCP"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.18553\/jmcp.2010.16.6.402","type":"journal-article","created":{"date-parts":[[2016,2,21]],"date-time":"2016-02-21T14:39:35Z","timestamp":1456065575000},"page":"402-416","source":"Crossref","is-referenced-by-count":11,"title":["Formulary Review of 2 New Biologic Agents: Tocilizumab for Rheumatoid Arthritis and Ustekinumab for Plaque Psoriasis"],"prefix":"10.18553","volume":"16","author":[{"given":"Jeremy A.","family":"Schafer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole K.","family":"Kjesbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick P.","family":"Gleason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7818","container-title":["Journal of Managed Care Pharmacy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2016,2,21]],"date-time":"2016-02-21T14:39:36Z","timestamp":1456065576000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jmcp.org\/doi\/10.18553\/jmcp.2010.16.6.402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["10.18553\/jmcp.2010.16.6.402"],"URL":"https:\/\/doi.org\/10.18553\/jmcp.2010.16.6.402","relation":{},"ISSN":["1083-4087","1944-706X"],"issn-type":[{"value":"1083-4087","type":"print"},{"value":"1944-706X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}